======= ATL2 ======= == Gene Information == * **Official Symbol**: ATL2 * **Official Name**: atlastin GTPase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=64225|64225]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NHH9|Q8NHH9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ATL2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ATL2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609368|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: GTPase tethering membranes through formation of trans- homooligomers and mediating homotypic fusion of endoplasmic reticulum membranes. Functions in endoplasmic reticulum tubular network biogenesis (PubMed:18270207, PubMed:19665976, PubMed:27619977). {ECO:0000269|PubMed:18270207, ECO:0000269|PubMed:19665976, ECO:0000269|PubMed:27619977}. |GBP| |GBP C| |endoplasmic reticulum tubular network membrane organization| |endoplasmic reticulum tubular network membrane| |endoplasmic reticulum tubular network organization| |endoplasmic reticulum organization| |Golgi organization| |endoplasmic reticulum to Golgi vesicle-mediated transport| |GTPase activity| |protein homooligomerization| |Golgi vesicle transport| |GTP binding| |endomembrane system organization| |protein complex oligomerization| |membrane organization| |endoplasmic reticulum membrane| |endoplasmic reticulum| |identical protein binding| |intracellular transport| |protein-containing complex assembly| |establishment of localization in cell| |protein-containing complex subunit organization| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp436|Dynasore 7μM R08 exp436]]|-2.48| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|-2.34| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-2.29| |[[:results:exp26|Oligomycin-A 20μM R00 exp26]]|-1.76| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-1.7| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|1.92| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|1.93| |[[:results:exp518|RK-33 8μM R08 exp518]]|1.98| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|2.49| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.559| Global Fraction of Cell Lines Where Essential: 213/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|6/28| |blood|9/28| |bone|7/26| |breast|7/33| |central nervous system|18/56| |cervix|0/4| |colorectal|5/17| |esophagus|2/13| |fibroblast|1/1| |gastric|4/16| |kidney|6/21| |liver|9/20| |lung|16/75| |lymphocyte|7/16| |ovary|8/26| |pancreas|3/24| |peripheral nervous system|7/16| |plasma cell|2/15| |prostate|0/1| |skin|12/24| |soft tissue|4/9| |thyroid|0/2| |upper aerodigestive|7/22| |urinary tract|10/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2066 * **Expression level (log2 read counts)**: 6.92 {{:chemogenomics:nalm6 dist.png?nolink |}}